期刊文献+

多剂静滴甲磺酸加替沙星氯化钠注射液耐受性试验 被引量:6

Investigation on the tolerance of gatifloxacin mehanesulfanae by a multi-dose intravenous infusion
下载PDF
导出
摘要 目的 :在中国健康志愿者中评价多剂静滴甲磺酸加替沙星氯化钠注射液的安全性和耐受性。方法 :选择健康成年男性志愿者 10名 ,恒速静脉滴注甲磺酸加替沙星氯化钠注射液 ,qd ,每次 4 0 0mg ,连续 14d。观察指标为临床症状、生命体征、心电图、血常规、尿常规、肝功能、肾功能、凝血功能、电解质等。结果 :试验结束后 ,健康志愿者体温、脉搏、呼吸频率、血压、心电图、血常规、肾功能、电解质等各项指标测定值均在正常范围内。本试验过程中仅发现 4例次可能与药物有关的不良反应 ,分别表现为AST ,ALT或γ 谷氨酰转移酶轻度升高 ,均为轻度一过性 ,可耐受 ,于停药后 1周内自行恢复。结论 :多剂静滴甲磺酸加替沙星氯化钠注射液 ,耐受性较好 。 Objective:To evaluate the safety and tolerance of gatifloxacin in Chinese healthy volunteers.Methods:After physical examination and laboratory tests were performed,10 healthy volunteers were administered with multi dose of 400mg gatifloxacin,qd for 14 days.Clinical symptoms,vital signs,routine blood tests, routine urine tests,hepatic function,renal function,clotting function,blood electrolytes,electrocardiogram,electroencephalogram were observed or examined before and after multi dose intravenous infusion of gatifloxacin.Results:It was shown that after multi dose intravenous infusion of 400mg gatifloxacin,the vital signs,clinical symptoms and laboratory tests were mainly in the normal range,but there were some slight ADRs that was concerned with the drug,such as ALT,AST or GGT increased,but the ADRs were found vanishing in one week.Conclusion:Multi dose intravenous infusion gatifloxacin in Chinese healthy volunteers is safe and tolerable.
出处 《中国新药杂志》 CAS CSCD 北大核心 2002年第11期875-878,共4页 Chinese Journal of New Drugs
关键词 多剂静滴 甲磺酸 替沙星氯化钠注射液 耐受性 gatifloxacin mehanesulfanae multi dose tolerance
  • 相关文献

参考文献8

  • 1Perry CM,Ormrod D, Hurst M, et al. Gatifloxacin: a review of its use in the management of bacterial infections[J]. Drugs, 2002,62(1):169-207.
  • 2Fish DN, North DS. Gatifloxacin,an advanced 8-methoxy fluoroquinolone [J]. Pharmacotherapy, 2001,21 (1): 35-59.
  • 3Honeybourne D, Banerjee D, Andrews J, et al. Concentrations of gatifloxacin in plasma and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy[J]. J Antimicrob Chemother, 2001,48(1): 63-66.
  • 4Nagai K,Davies TA,Dewasse BE, et al. Single-and multi-step resistance selection study of gemifloxacin compared with trovafloxacin, ciprofloxacin, gatifloxacin and moxifloxacin in Streptococcus pneumoniae [J ]. J Antimicrob Chemother , 2001,48(3) :365-374.
  • 5Aminimanizani A,Beringer P,Jelliffe R, et al. Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials[ J]. Clin Pharmacokinet ,2001,40(3): 169-187.
  • 6Vishwanathan K, Bartlett MG, Stewart JT, et al. Determination of gatifloxacin in human plasma by liquid chromatography/electrospray tandem mass spectrometry[J]. Rapid Commun Mass Spectrom ,2001,15(12) :915-919.
  • 7Naber CK, Steghafner M, Kinzig SM, et al. Concentrations of gatifloxacin in plasma and urine and penetration into prostatic and seminal fluid, ejaculate, and sperm cells after single oral administrations of 400 milligrams to volunteers [J]. Antimicrob Agents Chemother,2001,45(1) :293-297.
  • 8Perry CM, Balfour JAB, Lamb HM. Gatifloxacin [J]. Drugs,1999,58(4) :683-697.

同被引文献25

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部